Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives
Open Access
- 1 January 2017
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-10
Abstract
Pulmonary thromboembolism (PTE) is part of a larger clinicopathological entity, venous thromboembolism. It is also a complex, multifactorial disorder divided into four major disease processes including venous thrombosis, thrombus in transit, acute pulmonary embolism, and pulmonary circulation reconstruction. Even when treated, some patients develop chronic thromboembolic pulmonary hypertension. PTE is also a common fatal type of pulmonary vascular disease worldwide, but earlier studies primarily focused on the pathological changes in the blood component of the disease. With contemporary advances in molecular and cellular biology, people are becoming increasingly aware of coagulation pathways, the function of vascular smooth muscle cells, microparticles, and the inflammatory pathways that play key roles in PTE. Combined hypoxia and immune research has revealed that PTE should be regarded as a class of complex diseases caused by multiple factors involving the vascular microenvironment and vascular cell dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (81270107, 2016KYB149)
- Chinese Medicine Research Program of Zhejiang Province (81270107, 2016KYB149)
This publication has 136 references indexed in Scilit:
- Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 InflammasomePLOS ONE, 2013
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Plasma Kallikrein Promotes Epidermal Growth Factor Receptor Transactivation and Signaling in Vascular Smooth Muscle through Direct Activation of Protease-activated ReceptorsJournal of Biological Chemistry, 2010
- Signal transduction by protease‐activated receptorsBritish Journal of Pharmacology, 2010
- Mitochondrial reactive oxygen species regulate hypoxic signalingCurrent Opinion in Cell Biology, 2009
- Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunityCurrent Opinion in Pharmacology, 2009
- The many faces of tissue factorJournal of Thrombosis and Haemostasis, 2009
- Concentration dependent dual effect of thrombin in endothelial cells via Par‐1 and Pi3 KinaseJournal of Cellular Physiology, 2009
- Triggers, targets and treatments for thrombosisNature, 2008
- Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patientsThrombosis Research, 2008